E
ORGO icon

Ergoteles’s Organogenesis Holdings ORGO Stock Holding History

Ergoteles’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-165,565
Closed -$353K – 1381
2023
Q1 		$353K Buy
+165,565
New +$409K 0.01% 849
2022
Q4 		– Sell
-34,876
Closed -$113K – 1762
2022
Q3 		$113K Sell
34,876
-7,224
-17% -$32.6K ﹤0.01% 1342
2022
Q2 		$205K Buy
+42,100
New +$259K 0.01% 1314

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ergoteles's ORGO Position: Q2 2023 in Review

Ergoteles sold out of Organogenesis Holdings (ORGO) in Q2 2023, closing a stake of 165,565 shares — an estimated $353K sold.

Ergoteles first reported a position in ORGO in Q2 2022 and held it in 3 quarters. The position peaked at $353K in Q1 2023. 113 funds tracked by Wall St. Rank hold ORGO as of Q2 2023.

  • Ergoteles reported no remaining Organogenesis Holdings position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 165,565 Organogenesis Holdings shares in Q2 2023, an estimated $353K.
  • Ergoteles first reported a position in Organogenesis Holdings in Q2 2022 and held it in 3 quarters.
  • Ergoteles's Organogenesis Holdings position peaked at $353K in Q1 2023.
  • 113 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.